๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia

โœ Scribed by Wyatt, Richard J.; Deutsch, Stephen I.; Rosse, Richard B.; Kendrick, Kathleen A.; Fay-McCarthy, Maureen; Collins, Joseph P.; Rosenberg, Paul B.


Book ID
122899498
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
101 KB
Volume
15
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Safety, tolerability, and feasibility of
โœ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent